Human Papillomavirus
Proving and Using a Viral Cause for Cancer
- Publisher's listprice EUR 105.00
-
43 548 Ft (41 475 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 4 355 Ft off)
- Discounted price 39 194 Ft (37 328 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
43 548 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 25 November 2019
- ISBN 9780128144572
- Binding Paperback
- No. of pages460 pages
- Size 234x190 mm
- Weight 930 g
- Language English 0
Categories
Long description:
Human Papillomavirus: Proving and Using a Viral Cause for Cancer presents a steady and massive accumulation of evidence about the role of HPV and prevention of HPV-induced cancer, along with the role and personal commitment of many scientists of different backgrounds in establishing global relevance. This exercise involved years of personal commitment to proving or disproving an idea that aroused initial skepticism, and that still has difficult implications for some. It remains one of the big successes of medicine that exploited both established medical science dating back to the nineteenth century and new molecular genetic science during a time of transition in medicine.
MoreTable of Contents:
"
Section 1: Early questions and their slow answers
1. Introduction: Implications and responses to a possible specific infectious cause for a solid cancer, approaches to proving the role of HPV, and exploring its potential uses against conventional medical practice
2. Cervical and other cancers now associated with HPV prior to recognition of HPV in cervical cancer
3. Cervical screening and its basis in ideas of precancer in classical microscopic pathology
4. The ""discovery"" of HPV I6 in cervical cancer and studies of its transforming role, P53 and pRB
5. Growing numbers of carcinogenic papillomaviruses and understanding of their differences
6. The impact of HPV on conventional morphological pathology of cancer and precancer. Bethesda classification, molecular markers relating morphology to molecular mechanisms
7. The proof of causality in humans
8. Progression from infection to cancer
9. Sexuality and HPV: sexual transmission, male role
10. Genital warts
11. HPV and non-cervical cancer
12. Immune responses, and antibodies to HPV, making viral antigens
13. Developing and standardising HPV tests
14. HPV and non-HPV pathways to cancer
Section 2: Prevention of cancer and HPV infection
15. Introduction: Evidence-based medicine, HPV and cancer prevention
16. Triage of women with low-grade smear abnormalities and HPV testing, HC1 and 2, GP5+/6+, ALTS trial, Netherlands, other trials
17. Primary screening by HPV testing
18. Prophylactic vaccines, proving their value and the role and limitations of the pharmaceutical industry and its regulators, safety and efficacy
19. Modelling disease, prevention and cost-effectiveness - a developing process, different types of models, what does cost-effectiveness mean?
20. Changing global concerns about screening and vaccination
